Is This U.S. Pot Stock the New Industry Leader?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) may have been the dominant name in the cannabis industry thus far, but that might not be the case for much longer.

| More on:

Canopy Growth has tried to assert itself atop the cannabis industry in North America. It made a lot of aggressive moves to try and give itself and its investors a lot of potential growth to benefit from in the years ahead.

From locking in a big investor like Constellation Brands to getting a deal in place with Acreage Holdings, the company has made numerous moves to help position itself for success.

Access to U.S. market critical for long-term growth

The problem is that even if investors think Canopy Growth is a good investment, it’s inherently limited. Being restricted to the Canadian market and only being able to sell hemp-based products in the U.S. (for now) has put a limit on to just how much growth the company can achieve in the near future.

Even if the U.S. moves to legalize marijuana, that’s likely not going to happen anytime soon. That’s why Canopy Growth was always going to be a long shot to be the biggest cannabis brand, simply because it didn’t have access to the biggest cannabis market.

Multi-state operator Curaleaf Holdings (CNSX:CURA), however, doesn’t have those same obstacles. With the company not being on the TSX and based in the U.S., Curaleaf has a lot more flexibility in what it can do. And while federally there are still significant challenges, growing via acquisition is one way that the company can expand into other parts of the country, which is what it has done.

This week, Curaleaf released its second-quarter results. Its US$48 million in revenue during the quarter was a 231% improvement from the prior year. On a pro-forma basis, including the company’s acquisitions and assuming they had been completed on January 1, that number soars to US$110.9 million, which would dwarf what we’ve seen thus far from Canadian producers.

The company also reached a milestone on its bottom line as well, posting a positive adjusted EBITDA figure of US$3.4 million for the first time in its history. This was an improvement from the prior year when it incurred a loss of US$3.8 million.

Currently, through acquisitions, Curaleaf now has access to 19 states. With some big acquisitions under its belt already, the company is still expecting even more growth down the road.

In its earnings release, Curaleaf CEO Joseph Lusardi stated, “The recently announced acquisitions of Select and Grassroots, as well as, tuck in acquisitions in ArizonaCalifornia, Nevada, and Ohio position Curaleaf as the undisputed leader in the cannabis industry. With the industry’s largest operational footprint, we have the scale to rapidly accelerate growth across the country.”

More states looking to legalize pot

Thus far, we’ve seen 11 states in the U.S. legalize marijuana for recreational use. However, we could see that number grow, as both New York and New Jersey are two states that have shown interest in legalization, and other states are trying to get marijuana legalization on the ballot for 2020.

With more markets potentially becoming available, the growth potential for Curaleaf could get bigger very soon. For Canopy Growth, its path is not quite as clear.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »